Shares of MeiraGTx Holdings (MGTX) added ~17% to reach a 52-week high on Tuesday after the company scheduled a presentation to disclose data from an early-stage trial for its gene therapy, AAV-hAQP1.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results